Michael C. Welsh
Presidente en Almasa Capital, Inc. .
Perfil
Michael C.
Welsh is currently the President of Almasa Capital, Inc. He was previously the Chairman of Micralyne, Inc. and held director positions at Biomira, Inc. and Cascadian Therapeutics LLC.
He was also a partner at Welsh & Co. Mr. Welsh received an undergraduate degree from the University of Alberta.
Cargos activos de Michael C. Welsh
| Empresas | Cargo | Inicio |
|---|---|---|
| Almasa Capital, Inc. | Presidente | - |
Antiguos cargos conocidos de Michael C. Welsh.
| Empresas | Cargo | Fin |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Director/Miembro de la Junta | 11/12/2008 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Director/Miembro de la Junta | 11/12/2007 |
| Welsh & Co. | Corporate Officer/Principal | - |
Micralyne, Inc.
 Micralyne, Inc. Industrial MachineryProducer Manufacturing Micralyne, Inc. develops and manufactures micro fabricated products. It offers wafer level packaging, die level packaging, silicon optical bench and spatial light valve. The firm’s services are used in the areas of microfluidics and MEMs sensors. The company was founded in 1982 and is headquartered in Edmonton, Canada. | Presidente | - |
Formación de Michael C. Welsh.
| University of Alberta | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Health Services |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA. | Health Technology |
| Almasa Capital, Inc. | |
Micralyne, Inc.
Micralyne, Inc. Industrial MachineryProducer Manufacturing Micralyne, Inc. develops and manufactures micro fabricated products. It offers wafer level packaging, die level packaging, silicon optical bench and spatial light valve. The firm’s services are used in the areas of microfluidics and MEMs sensors. The company was founded in 1982 and is headquartered in Edmonton, Canada. | Producer Manufacturing |
| Welsh & Co. |
- Bolsa de valores
- Insiders
- Michael C. Welsh
